Articles with "eskd patients" as a keyword



Photo from wikipedia

Clinical characteristics and outcomes of antibiotic-associated encephalopathy in patients with end-stage kidney disease

Sign Up to like & get
recommendations!
Published in 2022 at "Renal Failure"

DOI: 10.1080/0886022x.2022.2134025

Abstract: Abstract Objective End-stage kidney disease (ESKD) patients have a higher risk of antibiotic-associated encephalopathy (AAE) than other patients. We aimed to evaluate the prevalence, risk factors and outcomes of AAE in ESKD patients. Method A… read more here.

Keywords: end stage; stage kidney; antibiotic associated; kidney disease ... See more keywords
Photo from wikipedia

P1458CONSERVATIVE MANAGEMENT VERSUS DIALYSIS IN ESKD PATIENTS WITH HIGH COMORBIDITY AND FRAILTY

Sign Up to like & get
recommendations!
Published in 2020 at "Nephrology Dialysis Transplantation"

DOI: 10.1093/ndt/gfaa142.p1458

Abstract: ESKD population is increasingly older, frail and with cumulative comorbidities. Conservative management (CM) is a valid approach in selected cases but less well studied than the dialytic or transplant treatment. The objective of our study… read more here.

Keywords: comorbidity; comorbidity frailty; population; dialysis ... See more keywords
Photo by jordanmcdonald from unsplash

Fatigability and the Role of Neuromuscular Impairments in Chronic Kidney Disease.

Sign Up to like & get
recommendations!
Published in 2022 at "American journal of nephrology"

DOI: 10.1159/000523714

Abstract: BACKGROUND The combination of neuromuscular impairments plus psychosocial aspects of chronic kidney disease (CKD) may predispose these patients to greater risk for experiencing increased levels of fatigability. There has been extensive clinical and scientific interest… read more here.

Keywords: eskd patients; ckd eskd; performance; neuromuscular impairments ... See more keywords
Photo by ldxcreative from unsplash

Machine learning-based investigation of the relationship between immune status and left ventricular hypertrophy in patients with end-stage kidney disease

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Cardiovascular Medicine"

DOI: 10.3389/fcvm.2023.1187965

Abstract: Background Left ventricular hypertrophy (LVH) is the most frequent cardiac complication among end-stage kidney disease (ESKD) patients, which has been identified as predictive of adverse outcomes. Emerging evidence has suggested that immune system is implicated… read more here.

Keywords: hypertrophy; immune status; machine; disease ... See more keywords
Photo from wikipedia

The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on Dialysis

Sign Up to like & get
recommendations!
Published in 2023 at "Biomedicines"

DOI: 10.3390/biomedicines11041026

Abstract: Left ventricular hypertrophy (LVH) is a common cardiovascular complication in end-stage kidney disease (ESKD) patients. We aimed at studying the association of LVH with adiponectin and leptin levels, cardiovascular stress/injury biomarkers and nutritional status in… read more here.

Keywords: leptin; dialysis; left ventricular; patients dialysis ... See more keywords